STudy of Aspirin Removal in Patients Supported by the Fully Magnetically Levitated CH-VAD Pump
Conditions
- LVAD (Left Ventricular Assist Device) Thrombosis
- LVAD
- LVAD (Left Ventricular Assist Device)
- LVAD-related GI Bleed
- Bleeding
- Thrombosis
- Stroke
- Hemocompatibility-related Adverse Event
- Ventricular Assist Device
- Aspirin
- Antiplatelet Therapy
- Antithrombotic Therapy
Interventions
- DRUG: Warfarin (INR 2-3) with placebo
- DRUG: Warfarin (INR 2-3) with aspirin
Sponsor
China National Center for Cardiovascular Diseases
Collaborators
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]